
Bicycle Therapeutics PLC
NASDAQ:BCYC

Intrinsic Value
The intrinsic value of one
BCYC
stock under the Base Case scenario is
8.22
USD.
Compared to the current market price of 7.22 USD,
Bicycle Therapeutics PLC
is
Undervalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Bicycle Therapeutics PLC
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Bicycle Therapeutics PLC
Balance Sheet Decomposition
Bicycle Therapeutics PLC
Current Assets | 856.1m |
Cash & Short-Term Investments | 793m |
Receivables | 46.4m |
Other Current Assets | 16.7m |
Non-Current Assets | 27.8m |
PP&E | 15.4m |
Other Non-Current Assets | 12.4m |
Free Cash Flow Analysis
Bicycle Therapeutics PLC
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Bicycle Therapeutics PLC
Revenue
|
25.7m
USD
|
Operating Expenses
|
-269.6m
USD
|
Operating Income
|
-243.8m
USD
|
Other Expenses
|
40.6m
USD
|
Net Income
|
-203.2m
USD
|
BCYC Profitability Score
Profitability Due Diligence
Bicycle Therapeutics PLC's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Score
Bicycle Therapeutics PLC's profitability score is 13/100. The higher the profitability score, the more profitable the company is.
BCYC Solvency Score
Solvency Due Diligence
Bicycle Therapeutics PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Score
Bicycle Therapeutics PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BCYC Price Targets Summary
Bicycle Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
BCYC
is 26.44 USD
with a low forecast of 13.13 USD and a high forecast of 50.4 USD.
Dividends
Current shareholder yield for BCYC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BCYC
stock under the Base Case scenario is
8.22
USD.
Compared to the current market price of 7.22 USD,
Bicycle Therapeutics PLC
is
Undervalued by 12%.